IceCure Medical (ICCM) FCF Payout Ratio Growth (1y) (2021 - 2026)
IceCure Medical (ICCM) FCF Payout Ratio Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.07 Bn | 193.46 Bn | 7.27 Bn | -16.90% |
| 2 | Stryker | 127.90 Bn | 124.43 Bn | 4.50 Bn | -8.00% |
| 3 | Medtronic | 118.84 Bn | 109.62 Bn | 6.41 Bn | 0.45% |
| 4 | Boston Scientific | 73.33 Bn | 72.79 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.46 Bn | 32.51 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.91 Bn | 31.81 Bn | 2.18 Bn | -88.24% |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | -11.29% |
| 9 | Steris | 23.12 Bn | 22.64 Bn | 684.20 Mn | 27.54% |
| 10 | IceCure Medical | 6.77 Mn | -5.26 Mn | 253,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -28.37% |
| Dec 31, 2025 | -205.59% |
| Sep 30, 2025 | 146.70% |
| Jun 30, 2025 | -57.76% |
| Mar 31, 2025 | 61.42% |
| Dec 31, 2024 | 135.19% |
| Sep 30, 2024 | -33.93% |
| Jun 30, 2024 | -15.19% |
| Mar 31, 2024 | -86.52% |
| Sep 30, 2023 | -171.43% |
| Jun 30, 2023 | -74.58% |
| Mar 31, 2023 | 72.84% |
| Sep 30, 2022 | -67.84% |
| Jun 30, 2022 | 209.79% |
| Mar 31, 2022 | 9.24% |
| Sep 30, 2021 | 3,272.08% |